5'-(4-fluorosulfonylbenzoyl)adenosine has been researched along with sb 202190 in 1 studies
| Studies (5'-(4-fluorosulfonylbenzoyl)adenosine) | Trials (5'-(4-fluorosulfonylbenzoyl)adenosine) | Recent Studies (post-2010) (5'-(4-fluorosulfonylbenzoyl)adenosine) | Studies (sb 202190) | Trials (sb 202190) | Recent Studies (post-2010) (sb 202190) |
|---|---|---|---|---|---|
| 215 | 1 | 3 | 651 | 0 | 202 |
| Protein | Taxonomy | 5'-(4-fluorosulfonylbenzoyl)adenosine (IC50) | sb 202190 (IC50) |
|---|---|---|---|
| Mitogen-activated protein kinase 13 | Homo sapiens (human) | 0.08 | |
| Bromodomain-containing protein 4 | Homo sapiens (human) | 2.95 | |
| Tyrosinase | Mus musculus (house mouse) | 0.03 | |
| Amine oxidase [flavin-containing] B | Rattus norvegicus (Norway rat) | 0.08 | |
| Casein kinase I isoform delta | Homo sapiens (human) | 0.188 | |
| Mitogen-activated protein kinase 12 | Homo sapiens (human) | 0.08 | |
| Mitogen-activated protein kinase 11 | Homo sapiens (human) | 0.1038 | |
| Mitogen-activated protein kinase 14 | Homo sapiens (human) | 0.0625 | |
| Tau-tubulin kinase 2 | Homo sapiens (human) | 9.34 | |
| large T antigen | Betapolyomavirus macacae | 4.87 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adams, JL; Carr, SA; Doyle, ML; Fisher, S; Gallagher, TF; Huddleston, MJ; Kassis, S; Kumar, S; Lee, JC; Livi, GP; McDonnell, PC; McLaughlin, MM; McNulty, D; Porter, TG; Seibel, G; Young, PR | 1 |
1 other study(ies) available for 5'-(4-fluorosulfonylbenzoyl)adenosine and sb 202190
| Article | Year |
|---|---|
Pyridinyl imidazole inhibitors of p38 mitogen-activated protein kinase bind in the ATP site.
Topics: Adenosine; Adenosine Triphosphate; Affinity Labels; Amino Acid Sequence; Binding Sites; Binding, Competitive; Calcium-Calmodulin-Dependent Protein Kinases; Calorimetry; Cloning, Molecular; Cross-Linking Reagents; Enzyme Inhibitors; Escherichia coli; HeLa Cells; Humans; Imidazoles; Kinetics; Mitogen-Activated Protein Kinases; Mutagenesis, Site-Directed; p38 Mitogen-Activated Protein Kinases; Pyridines; Recombinant Proteins; Saccharomyces cerevisiae | 1997 |